Yu W - Search Results

1

Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.

Yu W, Zhang Z, Min D, Yang Q, Du X, Tang L, Lin F, Sun Y, Zhao H, Zheng S, He A, Li H, Yao Y, Shen Z. Yu W, et al. Eur J Cancer. 2014 Apr;50(6):1125-36. doi: 10.1016/j.ejca.2014.01.030. Epub 2014 Feb 21. Eur J Cancer. 2014. PMID: 24565852

2

Metastatic osteosarcoma to the liver and the kidney: a case report and review of the literature.

Yu WX, Yao Y. Yu WX, et al. BMJ Case Rep. 2009;2009:bcr07.2008.0536. doi: 10.1136/bcr.07.2008.0536. Epub 2009 Feb 26. BMJ Case Rep. 2009. PMID: 21686756 Free PMC article.

3

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide.

Lin F, Wang Q, Yu W, Tang L, Zheng S, Sun Y, Shen Z, Yao Y, Dong Y. Lin F, et al. Among authors: yu w. Asia Pac J Clin Oncol. 2011 Sep;7(3):270-5. doi: 10.1111/j.1743-7563.2011.01406.x. Asia Pac J Clin Oncol. 2011. PMID: 21884438

4

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.

Min D, Lin F, Shen Z, Zheng S, Tan L, Yu W, Yao Y. Min D, et al. Among authors: yu w. Asia Pac J Clin Oncol. 2013 Mar;9(1):71-9. doi: 10.1111/j.1743-7563.2012.01560.x. Epub 2012 Jul 23. Asia Pac J Clin Oncol. 2013. PMID: 22897971

5

Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma.

Yu W, Tang L, Lin F, Li D, Wang J, Yang Y, Shen Z. Yu W, et al. Int J Oncol. 2014 Apr;44(4):1091-8. doi: 10.3892/ijo.2014.2295. Epub 2014 Feb 10. Int J Oncol. 2014. PMID: 24535005 Free PMC article.

6

Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute.

Yu WX, Tang LN, Lin F, Yao Y, Shen Z. Yu WX, et al. Oncol Lett. 2014 Nov;8(5):2243-2248. doi: 10.3892/ol.2014.2472. Epub 2014 Aug 21. Oncol Lett. 2014. PMID: 25289103 Free PMC article.

7

Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?

Yu W, Tang L, Lin F, Yao Y, Shen Z. Yu W, et al. Med Oncol. 2015 Jan;32(1):307. doi: 10.1007/s12032-014-0307-y. Epub 2014 Nov 29. Med Oncol. 2015. PMID: 25432694

8

High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.

Yu W, Tang L, Lin F, Yao Y, Shen Z, Zhou X. Yu W, et al. Surg Oncol. 2015 Mar;24(1):9-15. doi: 10.1016/j.suronc.2014.10.001. Epub 2014 Nov 14. Surg Oncol. 2015. PMID: 25453577 Review.

9

Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.

Zheng S, Qiao G, Min D, Zhang Z, Lin F, Yang Q, Feng T, Tang L, Sun Y, Zhao H, Li H, Yu W, Yang Y, Shen Z, Yao Y. Zheng S, et al. Among authors: yu w. Cancer Lett. 2015 Apr 1;359(1):36-46. doi: 10.1016/j.canlet.2014.12.001. Epub 2015 Jan 8. Cancer Lett. 2015. PMID: 25578779

10

Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis.

Yu W, Tang L, Lin F, Yao Y, Shen Z. Yu W, et al. J Neurooncol. 2015 Nov;125(2):427-33. doi: 10.1007/s11060-015-1934-7. Epub 2015 Sep 16. J Neurooncol. 2015. PMID: 26376655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,699 results

Search Page

Filters